Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.

Torsten Pietsch(University of Bonn), Andreas Waha, Anke Koch, Jürgen Kraus, Steffen Albrecht(McGill University), Jörg C. Tonn(University of Würzburg), Nils A. Sörensen(University of Würzburg), Frank Berthold(University of Cologne), Bettina Henk, Nicole Schmandt(University of Würzburg), Helmut K. Wolf, Andreas von Deimling(Translational Research in Oncology), Brandon J. Wainwright(University of Queensland), Georgia Chenevix‐Trench(Royal Women's Hospital), Otmar D. Wiestler, Carol Wicking(University of Queensland)
PubMed
June 1, 1997
Cited by 376

Abstract

Inactivating mutations in the PTCH gene, a human homologue of the Drosophila segment polarity gene patched, have been identified recently in patients with nevoid basal cell carcinoma syndrome. These patients are predisposed to various neoplasias including basal cell carcinomas and medulloblastomas (MBs). To determine the involvement of PTCH in sporadic MBs, which represent the most frequent malignant brain tumors in children, we screened for PTCH alterations in an unselected panel of 64 biopsy samples from 62 patients and four continuous MB cell lines, all derived from patients with sporadic MBs. Using single-strand conformational polymorphism analysis, we screened exons 2-22 and detected nonconservative PTCH mutations in 3 of 11 samples from sporadic cases of the desmoplastic variant of MB but none in 57 MBs with classical (nondesmoplastic) histology. In two of the tumors with mutations and in two additional desmoplastic cases, loss of heterozygosity was found at 9q22. These findings suggest that PTCH represents a tumor suppressor gene involved in the development of the desmoplastic variant of MB.


Related Papers

No related papers found

Powered by citation graph analysis